Audio Journal of Oncology Podcast Niraparib Quadruples Progression Free Survival in Platinum-Sensitive Ovarian Cancer Play Episode Pause Episode 1x 00:00 / 7:00 Subscribe Apple Podcasts Spotify RSS Feed COPENHAGEN, Denmark—Marked prolongation of...
Audio Journal of Oncology Podcast Cyclin-Dependent Kinase Inhibition Overcomes Endocrine Resistance in Advanced Breast Cancer Play Episode Pause Episode 1x 00:00 / 10:48 secs Subscribe Apple Podcasts Spotify RSS Feed DESCRIPTION COPENHAGEN...
Audio Journal of Oncology Podcast Adjuvant Checkpoint Inhibition Extends Disease-Free and Overall Survival in Patients with Stage III Melanoma Play Episode Pause Episode 1x 00:00 / 6:30 Subscribe Apple Podcasts Spotify RSS Feed COPENHAGEN...
The large randomized Prostate Testing for Cancer and Treatment (ProtecT) study reported in two linked papers in the New England Journal of Medicine—has found that in low and intermediate risk disease radical prostatectomy and radiotherapy did not...
OXFORD, UK—The massive ten-year randomized Prostate Testing for Cancer and Treatment (ProtecT) trial—published in the New England Journal of Medicine—of treatment for PSA-detected localized prostate cancer found that in most patients radical...
TURIN, Italy—All patients with Stage IIA testicular seminoma should be treated with radiotherapy rather than multi-agent chemotherapy according to conclusions from a study reported at the 2016 annual meeting of the European Society for Radiotherapy...
LONDON, UK—Whole brain radiotherapy brought no benefit to patients whose non-small cell lung cancer had metastasized to the brain in research findings published in The Lancet and presented at the European Respiratory Society (ERS) 2016 Congress held...
Audio Journal of Oncology Reporting from ESTRO 2016, Turin August 26th, 2016 Lung Cancer Radiation Therapy Increases Heart Disease Mortality Transcript of podcast as broadcast PETER GOODWIN: A warning now about the collateral damage that...
Audio Journal of Oncology Young Patients With Early Breast Cancer Live Longer With Mastectomy September 1, 2016 Transcript of the podcast as broadcast: PETER GOODWIN: Younger women with early breast cancer treated with mastectomy had lower...
SAN FRANCISCO— The orally administered androgen receptor blocker enzalutamide significantly extended both overall survival and radiographically determined progression-free survival in men whose metastatic castration-resistant prostate cancer was...
SAN FRANCISCO—The length of time from nephrectomy up until the diagnosis of metastatis has been confirmed as prognostic for patients whose renal cell carcinoma was treated with targeted therapies — just as it is in patients overall — according to a...
SAN FRANCISCO— Gleason score at initial diagnosis was not predictive of response to abiraterone in patients with metastatic castration-resistant prostate cancer in a pooled analysis of three trials of abiraterone acetate therapy presented at the...